Jounce Therapeutics, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (2)

Latest Posts

About This Stock More About This Stock
E Buy Jounce For A Bounce
Article By: Quad 7 Capital
Friday, May 18, 2018 11:45 AM EDT
Jounce Therapeutics announced it will present data at the ASCO conference for its candidate JTX-2011, and the Street interpreted the abstract negatively. We see this selloff as an overreaction, and one we can take a gamble on.
In this article: JNCE Also: CELG
Read
4 Small Cap Biotechs With Upcoming Catalysts
Article By: Scott Matusow
Wednesday, January 10, 2018 7:20 PM EDT
The biotech “run-up” trade has always attracted a wide array of traders looking to take advantage of potentially high alpha price moves before the actual catalyst/binary event come to fruition.
In this article: JNCE, MYOK, GTHX, SRRA Also: MRK, RHHBY, VRTX, LLY, XBI
Read
Cool Tech IPOs Finally Emerge After Drought
Article By: Jon Markman
Tuesday, February 21, 2017 2:17 PM EDT
It has become a cliché. If your business is not scarfing up new technology, it’s being devoured by it. Given the choice, companies are choosing to eat... with more than $3.6 trillion in deals announced,
In this article: CSCO, ANAB, JNCE, NTNX, TWLO, ACIA, PI
Read

PARTNER HEADLINES

Latest Tweets for $JNCE

No tweets yet!